As the industry’s first open, SaaS-based clinical ecosystem, Cognizant SIP connects sponsors, sites and technology providers working at home or other locations.

The metaverse can bridge the physical and digital worlds to advance science. This could pave the way for new digital approaches to more value-based models that incentivize measurable real-world patient outcomes.

The role of AI in life sciences is moving rapidly from “potential” to “innovative” to “necessary.” And as it does, the industry’s obligation to be responsible and compliant becomes ever-more important.

Here are four ways life sciences organizations can quickly and cost-effectively achieve Manufacturing 4.0 benefits while still getting treatments to market.